Meanwhile, the AHR-mediated upregulation of CD39 has been demonstrated to simultaneously cooperate with CD73 in the generation of adenosine monophosphate (AMP) from ATP and produce nucleotide adenosine, causing the suppression of CD8+ T cell immunity and the immune evasion of GBM (50–52). The gene discussed is AHR; the disease is glioblastoma.